Dominic Piscitelli
Director of Finance/CFO chez ORIC PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/03/2024
Postes actifs de Dominic Piscitelli
Sociétés | Poste | Début | Fin |
---|---|---|---|
ORIC PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/09/2019 | - |
Public Communications Contact | - | - | |
CELYAD ONCOLOGY SA | Director/Board Member | 06/05/2020 | - |
Independent Dir/Board Member | 06/05/2020 | - |
Historique de carrière de Dominic Piscitelli
Anciens postes connus de Dominic Piscitelli
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANAPTYSBIO, INC. | Director of Finance/CFO | 11/01/2017 | 16/08/2019 |
Investor Relations Contact | 11/01/2017 | 16/08/2019 | |
MEDIVATION INC | Director of Finance/CFO | 01/09/2012 | 01/01/2017 |
Investor Relations Contact | 01/09/2012 | 01/01/2017 | |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 01/09/2011 | 01/09/2012 |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Treasurer | 01/01/2009 | 01/01/2011 |
Formation de Dominic Piscitelli
Hofstra University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 6 |
Belgique | 2 |
Grèce | 2 |
Opérationnelle
Director of Finance/CFO | 3 |
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
ORIC PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Astellas Pharmaceuticals SA |
- Bourse
- Insiders
- Dominic Piscitelli
- Expérience